Leflunomide - Rheumatology indications
You are here : Home > Formulary Search > Leflunomide - Rheumatology indications
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
Shared Care
Shared Care
Shared Care
PAD Profile
ChemicalSubstance :
Leflunomide
Indication :
Rheumatology indications
Group Name :
Keywords :
RMOC, national shared Care, Vasculitis (off label), Rheumatoid Arthritis, Psoriatic Arthritis, SLE (off label), Systemic Lupus Erythematosus (off label) , axial spondyloarthropathy (off label)
Brand Names Include :
Arava
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
4
Other Indications
Below are listed other indications that Leflunomide is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Rheumatology indications.
Committee Recommendations (2)
The Surrey Heartlands Integrated Care System Area Prescribing Committee have agreed a local adaptation of the National Shared Care document, in reference to the routine monitoring of CRP (rather than ESR) in primary care for inflammatory indications
The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) approve the RMOC national shared care protocol with ‘local adaptations.
The local adaptation is:
Specialist Responsibilities
- The initiating specialist will be expected to initiate and optimise treatment and prescribe the maintenance treatment for at least 12 weeks and until optimised.